We are live on
!
Find out more
KL
KCK Ltd Portfolio holdings
AUM
$15.1M
1-Year Est. Return
30.14%
This Fund
S&P 500
This Quarter
Est. Return
-28.03%
1 Year Est. Return
+30.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
–
Cap. Flow
+$179M
Cap. Flow
% of AUM
126.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sight Sciences
SGHT
|
+$105M |
| 2 |
Neuropace
NPCE
|
+$73M |
| 3 |
Immunic
IMUX
|
+$628K |
| 4 |
RNTX
Rein Therapeutics
RNTX
|
+$500K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sight Sciences
SGHT
$286M
| $83.9M | 59.26% |
+4,776,232
| New | +$105M |
|
|
2
Neuropace
NPCE
$439M
| $56.7M | 40.01% |
+5,621,111
| New | +$73M |
|
|
3
Immunic
IMUX
$190M
| $667K | 0.47% |
+6,970
| New | +$628K |
|
|
RNTX
4
Rein Therapeutics
RNTX
$63.1M
| $362K | 0.26% |
+32,341
| New | +$500K |
|
Similar funds
LM
AVM
RCMU
TPC
SI
TAC
DADR
PM
KCK Ltd's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for KCK Ltd, which disclosed 4 positions worth $142M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Sight Sciences: 4,776,232 shares worth $83.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- KCK Ltd's largest Q4 2021 buy was Sight Sciences: 4,776,232 shares worth $83.9M.
- KCK Ltd's ten largest holdings make up 100% of its $142M portfolio in Q4 2021.
- KCK Ltd disclosed 4 positions in Q4 2021, its first 13F filing on record.
Based on KCK Ltd's 13F filing for Q4 2021, filed 11 Feb 2022.